How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
We have an incredible opportunity to leverage the lessons of the last year to make an even greater impact in 2022. At USP, we are resolving to accelerate our global health efforts in four central areas.
We live in an age where the use of computers and software systems are directly integrated into the practice and delivery of healthcare. This digitization of healthcare has led to innovations such as electronic health records, telemedicine, wearable devices, and even digital therapeutics.
Universal health coverage requires access to quality-assured medicines. Unfortunately, substandard and falsified medicines are highly prevalent in all those countries where under-resourced regulatory aut
When a problem puts millions of lives at risk, costs economies billions of dollars and undermines decades of hard-earned health progress, it deserves prompt and strategic attention. I’m describing the consequences of poor-quality medicines – a worldwide problem that deserves worldwide attention.
Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.
Show 11 More